Table 3.

The IeDEA-CA adult clinical cohort characteristics by country, overall and stratified by sex

	Program sites in Burundi				Program sites in Cameroon				Program sites in DR Congo				Program sites in Rwanda
Number of sites	1				3				6				2
Number of adult patients (n)	2223				4922				9871				4583
Sex
Female, n (%)a	1536 (69)				3437 (70)				6726 (68)				3095 (68)
Male, n (%)a	686 (31)				1482 (30)				3096 (32)				1488 (32)
Missing, n	1				3				49				0
	All (%)a	Female (%)	Male (%)	p b	All (%)a	Female (%)	Male (%)	p b	All (%)a	Female (%)	Male (%)	p b	All (%)a	Female (%)	Male (%)	p b
Socio-demographics
Age (years; mean)	38	36	42	<0.05c	38	37	41	<0.05c	40	38	43	<0.05c	34	32	38	<0.05c
Marital status
Married	35	28	52		33	24	53		42	32	64		30	25	41
Single/living together but  not married	32	33	31	<0.05	47	51	36	<0.05	23	25	19	<0.05	53	54	51	<0.05
Divorced	9	11	7		5	6	3		11	13	7		2	2	1
Widowed	23	28	11		16	19	7		24	31	11		15	19	7
Missing (n)	1	1	0		0	0	0		415	296	96		1876	1315	561
Perceived discordancy with partner
Yes	7	6	10	<0.05	20	17	26	<0.05	8	7	11	<0.05	30	27	38	<0.05
No	35	29	50		23	20	30		23	21	28		13	10	17
Do not know	16	18	12		32	33	29		46	47	45		12	14	7
N/A or missing	41	46	28		25	30	15		23	26	16		45	49	38
Pregnant
Yes		4				4				3				15
No		96				96				97				85
Missing (n)		2				0				47				0
Clinical characteristics
WHO Clinical Stage
I	33	33	33	0.10	16	17	12	<0.05	9	10	8	0.09	64	67	59	<0.05
II	17	17	16		19	20	18		24	24	24		33	31	36
III	36	37	34		50	50	52		61	61	61		3	2	5
IV	14	13	17		15	13	18		6	6	6		0	0	0
Missing (n)	7	4	2		17	8	6		125	73	31		1359	830	529
CD4 count (median)		318	253	<0.05d		219	182	<0.05d		235	187	<0.05d		440	306	<0.05d
missing (n)		700	323		861	611	248		8009	5418	2556		3823	2560	1263
ART
Initiated prior to enrolment	50	52	43	<0.05	49	49	47	0.62	27	28	27	0.57	0.1	0.2	0	0.19
Initiated at enrolment	5	5	7		36	36	38		2	1	2		6	5	6
Stopped at enrolment	1	0.8	0.3		0.1	0.1	0.1		0.4	0.4	0.4		0	0	0
Never (ART-naïve)	44	42	50		15	15	15		71	70	71		94	94	94
Missing (n)	8	6	1		18	9	6		133	75	35		0	0	0
Entry to HIV care
VCT	81	79	84	<0.05	40	39	42	<0.05	56	56	57	<0.05	55	50	67	<0.05
PMCTC	3	4	0		4	6	0.3		0.6	0.8	0.2		24	31	9
TB/STI clinic or other	14	14	13		32	30	35		10	10	9		21	19	24
No previous care	3	3	3		25	25	23		33	33	33		0	0	0
Missing (n)	71	50	21		3	0	0		93	46	21		0	0	0
TB therapy
Yes	4	3	7	<0.05	5	4	6	<0.05	5	5	6	<0.05	0.1	0.1	0.1	0.97
No	96	97	93		95	96	94		95	95	94		100	100	100
Missing (n)	8	6	1		8	3	2		124	68	28		0	0	0

ART, antiretroviral therapy; IeDEA-CA, International Epidemiologic Databases to evaluate AIDS Central Africa; IQR, interquartile range; PMTCT, prevention of mother-to-child transmission of HIV; SD, standard deviation; STI, sexually transmitted infection; TB, tuberculosis; VCT, voluntary counseling and testing for HIV prevention; WHO, World Health Organization.

^aPercentages calculated among the non-missing responses

^bp values derived from χ² tests of equivalence

^cStudent's t-test of equality of means

^dtest of equality of medians.